An open-label study of 80 patients with irritable bowel syndrome (IBS) found that those who knew they were receiving a placebo still experienced improvements, including reduced symptom severity, compared to those who did not receive any additional treatment. Read more at here.
Placebos without deception effective for IBS
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
